Patient Recruitment

Selected news for the healthcare topic - Patient Recruitment, collected since 10/2017. Recent stories appear in baseballnewssource.com and Benzinga. This healthcare topic shares news with COVID-19, Clinical Research, Clinerion, Clinical Trial Recruitment, Pfizer and over a hundred others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
2/20/2021 Analyzing Centogene (NASDAQ:CNTG) & American Shared Hospital Services (NYSE:AMS) baseballnewssource.com ... platform analyzes epidemiologic, phenotypic, and genetic data to enhance the understanding of rare hereditary diseases. The company operates through two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Diagnostics segment provides genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and ...
2/19/2021 The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko Benzinga ... NASDAQ: SLN ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Feb. 19)Avidity Biosciences Inc (NASDAQ: RNA ) Biophytis SA ADR (NASDAQ: BPTS ) (received regulatory nod in France and Belgium for expansion of patient recruitment for Part 2 of the Phase 2/3 COVID-19 study) Bioventus Class A Ord Shs (Proposed) (NASDAQ: BVS ) Pharming Group N V ADS each representing 10 Ord Shs (NASDAQ: PHAR ) Sana Biotechnology Inc (NASDAQ ...
2/18/2021 Nordic Nanovector Sees Significant Improvement in Patient Recruitment Rate in PARADIGME, its Single-arm Phase 2 Pivotal Trial with Betalutin® in R/R Follicular Lymphoma cision.com Nordic Nanovector Sees Significant Improvement in Patient Recruitment Rate in PARADIGME, its Single-arm Phase 2 Pivotal Trial with Betalutin® in R/R Follicular Lymphoma Thu, Feb 18, 2021 06:59 CETOslo, Norway, 18 February 2021Nordic Nanovector ASA (OSE: NANOV) provides an update on PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® ( 177 Lu lilotomab satetraxetan) in 3 rd -line relapsed/refractory follicular lymphoma (3L R ...
2/17/2021 Study Says Decentralized Trials Rebounded More Quickly from COVID-19 Disruptions acrpnet.org February 17, 2021Rohit Nambisan, President, LokavantA new study confirms what many suspected about a tumultuous year for conducting clinical trials: Patient recruitment and retention dropped across the industry in early 2020, due to global quarantines and stay-at-home orders. However, the study also found decentralized clinical trials (DCTs) rapidly returned to pre-pandemic recruitment and retention levels while traditionally designed clinical trials had yet to recover through ...
2/17/2021 Analyzing Centogene (NASDAQ:CNTG) & American Shared Hospital Services (NYSE:AMS) dispatchtribunal.com ... platform analyzes epidemiologic, phenotypic, and genetic data to enhance the understanding of rare hereditary diseases. The company operates through two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Diagnostics segment provides genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and ...
2/17/2021 The Ridgway Record ridgwayrecord.com ... are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces that patient recruitment will begin in France and Belgium for Part 2 of its COVA Study assessing Sarconeos (BIO101) as a potential treatment for acute respiratory failure associated with COVID-19.Following the Data Monitoring Committee (“DMC ...
2/17/2021 Biophytis Announces Expansion of Patient Recruitment for Part 2 of the Phase 2-3 COVA Trial (“COVA Study”) Following Regulatory Authorities Approvals in France and Belgium itbusinessnet.com ... are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces that patient recruitment will begin in France and Belgium for Part 2 of its COVA Study assessing Sarconeos (BIO101) as a potential treatment for acute respiratory failure associated with COVID-19.Following the Data Monitoring Committee (“DMC ...
2/17/2021 How to manage risks in clinical studies Top 5 tips - Pepgr… flickr.com Pepgra provides tips to manage risks in clinical studies while preserving patient safety and data reliability in Patient recruitment for clinical trials ...
2/17/2021 Biophytis Announces Expansion of Patient Recruitment for Part 2 of the Phase 2-3 COVA Trial (“COVA Study”) Following Regulatory Authorities Approvals in France and Belgium firstwordpharma.com ... are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces that patient recruitment will begin in France and Belgium for Part 2 of its COVA Study assessing Sarconeos (BIO101) as a potential treatment for acute respiratory failure associated with COVID-19.Following the Data Monitoring Committee ("DMC ...
2/17/2021 Addressing the challenge of patient recruitment for clinical trials with the help of NLP and data science pharmaleaders.com Addressing the challenge of patient recruitment for clinical trials with the help of NLP and data science by Avenga and authored by: Igor Kruglyak, Senior Advisor at the global IT service provider Avenga and a 35+ year veteran executive of global key development and deployment projects, and Michael DePalma, Founder and President of Pensare, LLC; Co-Founder of Hu-manity.co, The Human API. Holder of 3 US patents and a ...
2/16/2021 A New Paradigm for Patient Recruitment financialbuzz.com ... on global testing, frequency, and accuracy A platform for screening and companion diagnostic testing across Europe and Africa Connecting real-world laboratory data from clinical sites and digitizing patient data, this partnership will optimize patient recruitment for precision medicine by identifying patients expected to respond to your product — moving efficiently into clinical trials and allowing patients to receive information on new therapies at the right time About Cerba Research ...
2/16/2021 OpenClinica and Quantum Leap Healthcare Collaborative Awarded Support to Power Expansion of the I-SPY COVID Trial inyoregister.com ... the trial’s significant life-saving potential drove a major contract to Quantum Leap Healthcare to expand and accelerate their efforts. The investment is being used to scale the phase 2 clinical trial, boost patient recruitment , and accelerate data collection by extending the trial into non-academic hospitals and non-research centers.“We initially built a relationship with Quantum Leap Healthcare when our clinical trial software supported their signature breast ...
2/16/2021 OpenClinica and Quantum Leap Healthcare Collaborative Awarded Support to Power Expansion of the I-SPY COVID Trial einnews.com ... the trial’s significant life-saving potential drove a major contract to Quantum Leap Healthcare to expand and accelerate their efforts. The investment is being used to scale the phase 2 clinical trial, boost patient recruitment , and accelerate data collection by extending the trial into non-academic hospitals and non-research centers.“We initially built a relationship with Quantum Leap Healthcare when our clinical trial software supported their signature breast ...
2/16/2021 Patient Recruitment and Retention Services Market is moving towards with tremendous growth by Abnex , Allscripts, Access Clinical Research, Acurian, Accurate Clinical Research, AD VERBUM mathematicexperts.com Market Size and Growth RateMarket Trend and TechnologicalCompany Market ShareTable of Contents for market shares by application, research objectives, market sections by type and forecast years considered. Patient Recruitment and Retention Services Market Share by Key Players : Here, capital, revenue, and price analysis by the business are included along with other sections such as expansion plans, areas served, products presented by key manufacturers, alliance and acquisition and ...
2/16/2021 A New Paradigm for Patient Recruitment pharmavoice.com Leveraging Medical Laboratory Data for Patient RecruitmentGHENT, Belgium– Cerba Research , a leading healthcare diagnostic company and wholly owned subsidiary of Cerba Healthcare, today announced a new partnership with Biokortex , a provider of digital solutions to the healthcare sector. This partnership will leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity. “Cerba Healthcare and Cerba Research are committed to investing ...
2/12/2021 Kintara Therapeutics Announces Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update | News | wfmz.com wfmz.com ... VAL-083 drug along with the funding to support the VAL-083 arm of the study. In turn, GCAR will manage all operational aspects of the study, including site activation and patient enrollment. Initiated patient recruitment for the VAL-083 study arm of GBM AGILE. Announced that VAL-083 is the only therapeutic agent currently being evaluated in all three GBM patient subtypes in GBM AGILE: newly-diagnosed methylated MGMT ...
2/8/2021 KTRA: Potential Market in MGMT-methylated GBM Zacks Sign up to SCR Digest, our FREE weekly newsletter, and receive our Notes emailed directly to you. Click here . KTRA: Potential Market in MGMT-methylated GBM 02/08/2021By John Vandermosten, CFANASDAQ:KTRAIn January, Kintara Therapeutics (NASDAQ:KTRA) announced the start of patient recruitment in the Global Coalition for Adaptive Research (GCAR) registrational Phase II/III clinical trial for glioblastoma multiforme (GBM). Kintara’s candidate, VAL-083, will be ...
2/4/2021 Hansa Biopharma year-end report Jan-Dec 2020 cision.com Hansa Biopharma year-end report Jan-Dec 2020 Thu, Feb 04, 2021 08:00 CETCommercial launch activities for Idefirix ® progressing as planned; Patient recruitment in clinical studies reinitiated in December 2020; Company financed into 2023Lund February 4, 2021. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January – December, 2020.Highlights for the ...
2/4/2021 TMG360 Media Announces Appointment of Kayleen M. Brown as Vice President Yahoo News SAN FRANCISCO , Feb. 4, 2021 /PRNewswire/ -- Kayleen M. Brown has been appointed Vice President of TMG360 Media, the new digital platform created to drive brand awareness, patient recruitment , strategic partnerships and funding access in the healthtech industry.TMG 360 Media (PRNewsfoto/TMG 360 Media) In her new role, Brown will manage the TMG360 newsroom and the team of healthtech journalists, covering market and industry trends, product launches and government affairs ...
2/4/2021 ACRP Calls for Renewed Efforts to Diversify Clinical Trials Workforce acrpnet.org ... trial staff] are hired, those are the trials that tend to hit minority recruitment targets.” Kremidas spent 24 years with Eli Lilly and Company. From 1999 to 2008, he led its clinical trial patient recruitment and retention efforts. In this role, he focused on predicting and accelerating the enrollment rates for all corporate studies.During the webinar, among other current initiatives, Kremidas outlined ACRP’s successful, and recently expanded ...